期刊文献+

痰湿壅盛证型原发性高血压病中医护理干预的临床效果 被引量:7

Clinical efficacy of TCM nursing intervention for primary hypertension of Phlegm-dampness type
下载PDF
导出
摘要 目的探讨痰湿壅盛证型原发性高血压病中医护理干预的临床效果。方法选择2014年1-6月在我院治疗的痰湿壅盛证型原发性高血压病患者80例为研究对象,根据入院单双数原则分为干预组和对照组各40例。对照组给予常规护理,干预组在常规护理基础上给予中医护理。比较两组的临床效果。结果两组治疗后中医证候积分均显著下降(P〈0.01);干预组治疗后中医证候积分显著低于对照组(P〈0.01)。干预组干预后1周,收缩压及舒张压均显著下降(P〈0.05)。两组间比较,干预后1周、4周,干预组患者收缩压及舒张压均显著低于对照组(P〈0.05)。干预组总有效率94.3%,对照组总有效率82.4%,两组比较,差异无统计学意义(P〉0.05)。结论中医护理干预能够显著改善痰湿壅盛证型原发性高血压患者的中医证候,改善患者的降压效果,值得临床推广。 Objective To discuss clinical efficacy of TCM nursing intervention for primary hypertension of Phlegm-dampness type. Methods 80 cases with primary hypertension of Phlegm-dampness type from Jan to Jun 2014 were Selected and divided into intervention group and control group, each of 40 cases. Control group was nursed with routine care, and intervention group was nursed with TCM nursing intervention bases on routine care. Clinical efficacy of two groups was compared. Results After intervention, TCM syndrome score of two groups decreased(P〈0.01);After intervention, TCM syndrome score of intervention group was lower than control group(P〈0.01); One week after the intervention,SBP and DBP of intervention decreased(P〈0.01);One week and four weeks after the intervention, SBP and DBP of intervention were lower than control group(P〈0.01). Total efficiency of intervention group was 94.3%, and control group was 82.4%, which showed no significant difference(P〉0.05). Conclusion TCM nursing intervention for primary hypertension of Phlegm-dampness type can decrease TCM syndrome score, and improve antihypertensive effect, worthy of clinical promotion.
出处 《中国现代医生》 2015年第33期139-142,共4页 China Modern Doctor
基金 浙江省中医药科技计划项目(2014ZA122)
关键词 原发性高血压病 痰湿壅盛证 中医护理 收缩压 舒张压 Primary hypertension Phlegm-dampness type Phlegm-dampness type SBP DBP
  • 相关文献

参考文献15

二级参考文献76

共引文献375

同被引文献61

  • 1熊宁,彭志群,吴金飞,罗恋.肾血管性高血压与原发性高血压患者动态血压的差异研究[J].东南国防医药,2013,15(2):144-146. 被引量:3
  • 2Cooper CJ,Murphy TP,Cutlip DE,et al.Stenting and medical therapy for atherosclerotic renal-artery stenosis[J].N Engl J Med,2014,370(1):13-22.
  • 3Pierdomenico SD,Pierdomenico AM,Cuccurullo C,et al.Cardiac events in hypertensive patients with renal artery stenosis treated with renal angioplasty or drug therapy:Meta-analysis of randomized trials[J].Am J Hypertens,2012,25(11):1209-1214.
  • 4刘力生,龚兰生.中国高血压防治指南(2005年版)[M].北京:人民卫生出版社,2005.
  • 5Rossi GP,Seccia TM,Miotto D,et al.The medical and endovascular treatment of atherosclerotic renal artery stenosis(METRAS)study:rationale and study design[J].J Hum Hypertens,2012,26(8):507-516.
  • 6Pang N,Xie C,Yang M,et al.Clinical efficacy of percutaneous transluminal renal artery stenting for the treatment of renovascular hypertension associated with Takayasu arteritis[J].Ann Vasc Surg,2015,29(4):816-821.
  • 7Maruyama K,Chinda J,Kabara M,et al.Successful percutaneous transluminal angioplasty for the treatment of renovascular hypertension with an atrophic kidney[J].Heart Vessels,2015,30(2):274-279.
  • 8Kaur S,Muthuraman A.Therapeutic evaluation of rutin in two-kidney one-clip model of renovascular hypertension in rat[J].Life Sci,2016,150(1):89-94.
  • 9Peco-Anti A,Staji N,Krsti Z,et al.Associated extrarenal vascular diseases may complicate the treatment and outcome of renovascular hypertension[J].Acta Paediatr,2016,105(1):e35-e41.
  • 10Jaff MR,Bates M,Sullivan T,et al.Significant reduction in systolic blood pressure following renal artery stenting in patients with uncontrolled hypertension:results from the Hercules trial[J].Catheter Cardiovasc Interv,2012,80(3):343-350.

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部